North America Joint Replacement Market Outlook, 2030

The North America joint replacement industry has evolved into one of the most technologically advanced and highly competitive sectors within the broader orthopedic market. Joint replacement, particularly of the knee and hip, has become an increasingly common procedure in the region due to a combination of aging demographics, higher life expectancy, and a growing prevalence of lifestyle-related conditions such as obesity and osteoarthritis. As the baby boomer population reaches retirement age and remains active longer, the demand for joint replacement procedures has surged dramatically.

Historically, these surgeries were reserved for elderly patients with severe joint damage, but advances in surgical techniques, implant materials, and pain management have shifted the focus toward younger, more active patients who wish to maintain their quality of life. This has reshaped the industry, compelling manufacturers to develop longer-lasting, more durable, and more biocompatible implants that can withstand years of use. Technological innovation has been a defining driver for the North America joint replacement market. Robotics-assisted surgeries, 3D-printed custom implants, and minimally invasive surgical techniques have all become increasingly mainstream.

Robotic-assisted surgery, for instance, has allowed surgeons to perform joint replacements with extraordinary precision, leading to improved implant alignment, faster recovery, and reduced complications. Companies such as Stryker, Zimmer Biomet, and Johnson & Johnson’s DePuy Synthes have heavily invested in these technologies, partnering with hospitals and surgical centers to roll out next-generation surgical solutions.

Moreover, 3D printing has opened the door for patient-specific implants, which better mimic the natural anatomy and reduce the risk of postoperative complications, thereby improving patient outcomes and satisfaction. These innovations have helped the industry address one of its persistent challenges implant longevities and are key to attracting a younger patient base who expect implants to last decades, not just years.

According to the research report “North America Joint Replacement Market Outlook, 2030” the North America Joint Replacement market is projected to grow with 4.52% CAGR by 2025-30. On the economic side, the North America joint replacement industry is a multi-billion-dollar market that has proven remarkably resilient even in the face of macroeconomic pressures.

The COVID-19 pandemic initially led to delays in elective procedures, including joint replacements, as hospitals prioritized critical care and intensive care resources. However, the market rebounded strongly as restrictions eased and elective surgeries resumed. The pent-up demand for joint replacements was so significant that many hospitals faced backlogs extending for months.

Additionally, public and private insurance reimbursement structures in the United States and Canada have largely supported access to joint replacement surgeries, although cost pressures remain an issue. As healthcare systems increasingly emphasize value-based care, joint replacement providers are under pressure to demonstrate measurable improvements in patient outcomes while keeping costs in check. This has spurred greater adoption of bundled payment models and performance-based incentives, encouraging surgeons and hospitals to focus on evidence-based best practices. Another important dimension is the ongoing shift in patient expectations and preferences.

Patients today are more informed than ever, thanks to digital platforms, social media, and online health forums. They demand faster recovery, less pain, and greater functionality after surgery, pushing healthcare providers to embrace enhanced recovery protocols and patient-centered preoperative education. Outpatient and same-day discharge joint replacement procedures are rising in popularity, thanks to improvements in pain management techniques, anesthesia, and surgical efficiency. This trend is reshaping care delivery by moving procedures away from traditional inpatient hospitals to ambulatory surgical centers, which can offer lower costs and a more streamlined patient experience. The result is a market that is not just growing in volume, but also transforming in how and where joint replacements are delivered.

Market Drivers

• Aging but Active Population: North America’s large baby boomer demographic is not only aging but staying active longer than previous generations. This unique cultural emphasis on maintaining mobility and independence well into retirement years is a major driver, pushing up demand for joint replacements at historically high rates.
• Technological Leadership and Adoption: : North America is uniquely positioned as a hub for medical innovation. Widespread adoption of robotic-assisted surgery, advanced biomaterials, and 3D-printed custom implants has created a strong push toward earlier, safer, and more durable joint replacement solutions, which continues to fuel growth.

Market Challenges

• Cost Containment and Value-Based Care Pressures: The U.S. and Canadian health systems are increasingly moving toward bundled payments and value-based care models, challenging hospitals and surgeons to balance high-tech implants and advanced procedures with affordability and measurable, evidence-backed outcomes.
• Elective Surgery Backlogs and Workforce Constraints: Even post-COVID, North America faces significant surgical backlogs, as well as orthopedic workforce shortages in certain regions, making it difficult to meet the high demand for joint replacements in a timely manner.

Market Trends

• Shift to Outpatient & Ambulatory Settings: Joint replacement procedures are increasingly moving out of traditional inpatient hospitals and into ambulatory surgical centers (ASCs), driven by improved pain management, minimally invasive techniques, and patient demand for quicker recovery and home-based rehabilitation.
• Patient Empowerment and Consumer-Like Behavior: North American patients are acting more like consumers than ever researching surgeons, demanding personalized options, tracking recovery outcomes, and expecting rapid return to full function, which is transforming how joint replacement care is delivered and marketed.

The knee procedure leads the North America joint replacement industry primarily because of the extremely high prevalence of osteoarthritis in the knee joint, driven by aging, obesity, and lifestyle factors.

Knee replacement has emerged as the dominant procedure in the North American joint replacement industry largely due to the widespread and growing burden of knee osteoarthritis, which affects millions of people across the United States and Canada. The knee is uniquely vulnerable to degeneration because it bears the brunt of excess body weight, repetitive stress from daily activities, and cumulative sports or work-related injuries over a lifetime. With obesity rates climbing and the population aging but remaining active, the incidence of knee osteoarthritis has skyrocketed, making knee pain one of the most common reasons patients seek orthopedic care.

Unlike the hip, where degenerative disease often progresses more gradually, the knee’s complex anatomy and the tremendous forces it absorbs with every step make it more susceptible to early cartilage wear and instability, creating severe pain and disability that strongly motivates patients to pursue surgical solutions. Moreover, advances in knee implant designs, minimally invasive techniques, and faster rehabilitation protocols have made knee replacement more predictable and accessible, encouraging more patients to undergo the procedure earlier in their disease progression.

Cemented fixation leads the North America joint replacement industry because it offers consistently strong, immediate, and predictable implant stability across a wide range of patients, including those with poor bone quality, which supports faster recovery and reliable outcomes.

In North America, cemented fixation has established itself as the dominant method of implant fixation in joint replacement procedures, particularly for knees and often for hips as well, thanks to its ability to deliver reliable, immediate mechanical stability regardless of a patient’s bone quality. Many patients undergoing joint replacement in North America are older and may have osteoporosis or other conditions that compromise bone density, making cemented fixation the safer and more predictable choice. By using bone cement to anchor the implant firmly to the surrounding bone, surgeons can achieve excellent initial fixation and load distribution, reducing the risk of early loosening or implant failure.

This, in turn, supports faster rehabilitation and allows patients to bear weight more confidently shortly after surgery a critical factor in North American healthcare systems that increasingly prioritize short hospital stays, rapid recovery, and cost-effective outcomes. Cemented techniques are also familiar and well-established among orthopedic surgeons in North America, with a strong evidence base showing decades of consistent performance.

While uncemented and hybrid options have grown in popularity for younger, active patients with good bone stock, cemented fixation remains the gold standard for the majority of the North American joint replacement population, delivering dependable outcomes for both surgeons and patients in a region that demands high reliability and reproducibility in orthopedic care.

Hospitals lead the North America joint replacement industry because they offer comprehensive surgical infrastructure, multidisciplinary teams, and advanced perioperative care essential for high-volume, complex joint replacement procedures.

In North America, hospitals have maintained their leadership in joint replacement procedures largely because they possess the complete ecosystem needed to safely and efficiently deliver these highly technical surgeries at scale. Joint replacement involves not only the surgical act itself but also preoperative assessment, anesthesia, specialized implants, sophisticated imaging, skilled nursing, and postoperative rehabilitation, all of which are most reliably available within hospital settings. Hospitals are equipped to manage complex cases, including patients with multiple comorbidities or those requiring revisions, and they have the necessary resources to handle unexpected intraoperative or postoperative complications.

Moreover, they employ multidisciplinary teams orthopedic surgeons, anesthesiologists, physical therapists, nurses, and infection control experts who work in an integrated manner to deliver coordinated, evidence-based care that supports faster recovery and better outcomes. Hospitals in North America are also often centers of excellence or teaching institutions, where surgeons have access to the latest technologies such as robotics, navigation systems, and advanced implant options, further reinforcing their dominant role.

Although outpatient surgery centers and ambulatory facilities are gaining traction, especially for healthy patients undergoing primary joint replacement, hospitals remain the backbone of the industry because they can accommodate the full spectrum of patient complexity and provide the highest standards of safety and clinical oversight, which are critical in a region with high patient expectations and rigorous quality demands.

The USA leads the North America joint replacement industry because of its highly advanced healthcare infrastructure, robust reimbursement systems, and widespread adoption of innovative surgical technologies.

The United States stands at the forefront of the North American joint replacement industry due to its unmatched healthcare infrastructure, which supports high surgical volumes with advanced facilities, world-class surgeons, and comprehensive perioperative care pathways. The country’s robust insurance and reimbursement systems, including Medicare and numerous private insurers, make joint replacement widely accessible to millions of patients, driving consistent demand. American hospitals and surgical centers are also early adopters of cutting-edge innovations from computer-assisted navigation and robotic-assisted surgery to 3D-printed patient-specific implants allowing them to deliver precise, predictable, and durable results.

Furthermore, a strong focus on patient-centered care, enhanced recovery after surgery (ERAS) protocols, and short hospital stays aligns perfectly with the demands of an aging yet highly active population that refuses to accept disability as inevitable. The USA also benefits from a mature network of medical device manufacturers, research institutions, and regulatory frameworks that accelerate the introduction of new implant technologies and surgical methods.

• In December 2023, Arthrex invested USD 30 million in R&D for minimally invasive joint reconstruction devices, focusing on faster recovery times and improved patient satisfaction. This initiative positioned Arthrex as a key innovator in the market.
• In October 2023, Smith+Nephew introduced antimicrobial coatings for its joint reconstruction devices, reducing post-operative infections by 25%. This innovation addressed a critical healthcare concern and boosted Smith+Nephew’s market reputation.
• In July 2023, DePuy Synthes partnered with Canadian distributors to expand its reach in emerging provincial markets. This collaboration resulted in a 15% increase in joint reconstruction procedures within six months.
• In April 2023, Stryker Corporation acquired OrthoSensor, a startup specializing in smart implant technologies. This acquisition enhanced Stryker’s capabilities in data-driven orthopedics, allowing it to offer comprehensive solutions for post-operative care.
• In February 2023, Zimmer Biomet launched the Persona IQ knee implant, featuring embedded sensors for real-time data monitoring. This innovation improved patient outcomes and solidified Zimmer’s leadership in the smart implant segment.

Considered in this report

• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report

• Joint Replacement Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Procedure Type

• Knee
• Hip
• Shoulder
• Others(Ankle,Elbow,Wrist, others)

By End-use

• Cemented Fixation
• Cementless Fixation
• Hybrid Fixation
• Reverse Hybrid Fixation

By Form

• Hospitals
• Ambulatory Surgical Centers
• Orthopedic Cinics

The approach of the report:

This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases.

After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to this industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.